In Silico Drug Repositioning Of Hydroxychloroquine (HCQ) For the Treatment of Viral Diseases

Emerging and re-emerging viral infections are a big human concern and veterinary public health, and the development of antiviral drugs is urgently needed. The high cost of drug development limit the scalability of this antiviral approach. Drug repositioning or drug repurposing or drug profiling is the discovery of new applications for approved or failed drug. Drug repositioning is the development of new approved drug applications. The cost of bringing a medicine to the market is around one million which include clinical and preclinical trials. Repositioning of drugs help in cutting down costs as well as time involve in initial validation and authorization. Recently, there are so many drugs that have been tried and tested for COVID-19 treatment .One of these drugs is an antimalarial drug called as Hydroxychloroquine (HCQ).